Sponsor Pipeline

Chang Chen Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07139041 Iparomlimab and Tuvonralimab Plus Chemotherapy for Inducing Conversion to Resectability… NSCLC (Non-small-cell Lung Cancer) Not Yet Recruiting
Phase 1
NCT07351565 Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in… Non-Small Cell Lung Cancer Not Yet Recruiting
Not specified
NCT07243964 Multi-Omics-Based Prediction of Allograft Dysfunction After Lung Transplantation Lung Diseases Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2)
Get alerts when Chang Chen's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free